ChromaDex Corporation (CDXC) financial statements (2021 and earlier)

Company profile

Business Address 10900 WILSHIRE BLVD
LOS ANGELES, CA 90024
State of Incorp. DE
Fiscal Year End December 31
SIC 2833 - Medicinal Chemicals and Botanical Products (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments17192345264
Cash and cash equivalents17192345264
Receivables(1)255622
Inventory, net of allowances, customer advances and progress billings121286884
Inventory121286884
Other undisclosed current assets5111000
Total current assets:32343757161710
Noncurrent Assets
Operating lease, right-of-use asset11
Property, plant and equipment3443321
Long-term investments and receivables    0  
Long-term investments    0  
Intangible assets, net (including goodwill)1122000
Intangible assets, net (excluding goodwill)1122000
Regulated entity, other noncurrent assets   0  0
Deposits noncurrent assets  00000
Other noncurrent assets110   0
Other undisclosed noncurrent assets   1  (1)
Total noncurrent assets:6766422
TOTAL ASSETS:38404263201912
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities1614147884
Accounts payable910104663
Accrued liabilities6444211
Employee-related liabilities   0   
Interest and dividends payable     00
Debt1100000
Due to related parties   0   
Deferred revenue and credits00000
Other undisclosed current liabilities0000020
Total current liabilities:16151489105
Noncurrent Liabilities
Long-term debt and lease obligation1100042
Long-term debt, excluding current maturities     32
Finance lease, liability00
Capital lease obligations00000
Operating lease, liability11
Liabilities, other than long-term debt44000(0)(0)
Deferred revenue and credits000(0)(0)
Deferred revenue44
Other undisclosed noncurrent liabilities  00000
Total noncurrent liabilities:5511143
Total liabilities:222015910138
Stockholders' equity
Stockholders' equity attributable to parent, including:162027541054
Common stock0000000
Additional paid in capital158142117110554743
Accumulated deficit(142)(122)(90)(57)(45)(42)(40)
Other undisclosed stockholders' equity attributable to parent(0)     0
Total stockholders' equity:162027541054
TOTAL LIABILITIES AND EQUITY:38404263201912

Income statement (P&L) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Revenues59463221272215
Revenue, net321272215
Revenue from related parties97 
Cost of revenue(24)(21)(16)(11)(15)(14)(10)
Gross profit:352616101285
Operating expenses(55)(57)(49)(27)(14)(11)(11)
Operating loss:(20)(31)(33)(16)(2)(2)(5)
Nonoperating expense(0)(1)(0)(0)(1)(1)(0)
Investment income, nonoperating   5000
Interest and debt expense(0)(1)(0)(0)(0)(1)(0)
Loss from continuing operations before equity method investments, income taxes:(20)(33)(33)(17)(3)(3)(6)
Other undisclosed income from continuing operations before income taxes   001 
Loss from continuing operations before income taxes:(20)(33)(33)(17)(3)(3)(6)
Income tax expense     (0) 
Loss from continuing operations:(20)(33)(33)(17)(3)(3)(6)
Income from discontinued operations   5   
Net loss:(20)(33)(33)(11)(3)(3)(6)
Other undisclosed net income attributable to parent010   0
Net loss available to common stockholders, basic:(20)(32)(33)(11)(3)(3)(5)
Dilutive securities, effect on basic earnings per share12      
Net loss available to common stockholders, diluted:(8)(32)(33)(11)(3)(3)(5)

Comprehensive Income ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Net loss:(20)(33)(33)(11)(3)(3)(6)
Comprehensive loss, net of tax, attributable to parent:(20)(33)(33)(11)(3)(3)(6)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: